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Abstract 
Lewis lung carcinoma of C57Bl/6 mice causes a 
progressive anemia with reticulocytosis and 
splenomegaly, metastasizes to lungs, liver, and kid-
neys but does not invade hemopoietic tissues. The 
cause of this anemia is uncertain. We studied the 
structure of spleen and bone marrow in these tumor 
hosts by light and electron microscopy. Splenic con-
gestion of the red pulp with numerous erythropoietic 
islands and marrow hyperplasia characterized the 
hemopoietic tissues of these mice , which, when 
coupled with other hematological parameters sug-
gested a hemolytic condition. However, the erythro-
poietic response appeared to be in part ineffective as 
evidenced by phagocytosis of immature as well as 
mature red blood cells within the spleen and marrow. 
Thus, the condition of anemia in Lewis lung carcino-
ma may result from a multifactorial response of he-
molysis and ineffective erythropoiesis and hemolysis. 
Key Words: Anemia, Lewis lung carcinoma, murine 
tumor system, cancer, spleen, electron microscopy, 
tumor-induced, hemopoiesis, erythropoiesis, eryth-
roclasia, hemolysis. 
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Introduction 
Lewis lung carcinoma (LLC) is an experimental 
tumor which can be maintained by subcutaneous 
transfer of tumor cells in C57Bl/6 mice (7, 9). It 
metastasizes to the lungs, liver and kidneys but not 
to hemopoietic organs (7). However, during the 
course of the disease the spleen becomes progres-
sively and massively enlarged and the animals de-
velop progressive anemia with reticulocytosis, sug-
gesting hemolysis (1, 4, 5). To gain further insight 
into the mechanism of this anemia, the structure of 
spleen and bone marrow of these tumor-bearing ani-
mals was studied by light and electron microscopy. 
The results support the suggestion of hemolysis and 
further indicated ineffective erythropoiesis. 
Materials and Methods 
Tumor System 
LLC was obtained from the Frederick Cancer 
Research Facility (Frederick, MD) and has been 
maintained in our laboratory by subcutaneous implan-
tation of 2 mm tumor fragments every 14 days into 
male C57Bl/6 mice, 18-20 grams (NCI). The method 
for its passage and maintenance and quality control 
has been described in detail (1, 4) and will not be 
repeated here . In the present work, each mouse re-
ceived a single-cell suspension of 106 viable LLC 
cells resuspended in Hanks' Balanced Salt Solution 
(HBSS). Our previous work has shown that the im-
plantation of this cell number results in 100% "take" 
with a median survival of 23 days. Control animals 
received an injection of equal volume of HBSS. This 
group is referred to here as "sham controls." 
Hematologic Studies 
At various times after tumor implantation, 
groups of animals (at least 5 per group) were sac-
rificed for hematologic studies. Heparinized whole 
blood was collected by cardiac puncture; hemoglobin, 
hematocrit, reticulocyte, total WBC, and differential 
WBC counts were determined. Reticulocyte counts 
were corrected for the hematocrit. Femoral bone 
marrow was harvested and total cell number per 
femur was determined and was not different in 
tumor-bearing and control animals (1, 4); a myeloid: 
erythroid ratio was ascertained on smears by count-
ing 500 cells. Splenic weight of each mouse was 
recorded at the time of marrow harvest. 
Microscopic Studies 
For hght microscopy spleen and marrow tissues 
from at least 5 animals per group were fixed in 10% 
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Figure 1. Light micrograph of a hematoxylin and 
eosm stained section of the spleen of an LLC-
bearing mouse 19 days post tumor implantation. 
Note congestion of the red pulp with numerous foci 
of hemopoiesis . Splenic sinuses contained evidence 
of intravascul a r erythropoiesis . (S) sinus . 
Table 1. Hematological parameters in LLC mice and 
sham controls 19 days post tumor implantation . 
Neutrophils /µ l 
(x 10-3) 
Hemoglobin 








LLC Sham Controls 
32 , 110 ± 8200 
5.5 + 0.3 
18 ± 1. 9 
8.3 ± 3.1 
1.5: 1 
362 ± 27.9 
2, 514 ± 1100 
12 . 0 ± 0.8 
37 ± 2 . 7 
1.7 ± 0.7 
1.2 : 1 
77 ± 1. 5 
formalin , buffered with phosphate buffered saline (pH 
7. 4) , dehydrated in ethanol, and embedded with par-
affin . Sections (3 microns in thickness) were stained 
with hematoxylin and eosin . 
For transmission electron microscopy (TE M) 
spleens and marrow tissues from at least 5 animals 
per group were removed, cut into small pieces about 
1-2 mm which gave approximately 4 samples for pro-
cessing per tissue and fixed in 4% cold glutaral-
dehyde in cacodylate buffer (pH 7 .3) overnight at 
4°C . The tissues were then post-fixed in similarly 
buffered 1% cold osmium tetroxide for 45 minutes at 
4°C . They were dehydrated in a graded series of 
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Figure 2. Electron micrograph of a section of red 
pulp of a spleen from an LLC mouse 14 days post 
implantation. Erythroblastic islands such as this one 
on which a central macrophage forms a focus of 
erythropoietic activity are seen throughout the red 
pulp. (E) erythroid cell. 
ethanol, infiltrated with Epon 812, and embedded in 
Epon 812. The samples were cured for 3 days in 
40°C and 60°C ovens and then were sectioned. Sec-
tions of 1 micrometer thickness were obtained with 
glass knives stained with alkaline toluidine blue (pH 
11) and ex amined by light microscopy. Suitable areas 
were then trimmed and thin sectioned with a dia-
mond knife in an LKB-5 microtome. Sections were 
stained with 2 . 5 % aqueous uranyl acetate for 1 h and 
0. 2% lead citrate for 5 minutes and observed in a 
JEOL 100 CX electron microscope (60 kV). 
Results 
Hematological parameters 
Hematological parameters in tumor-bearing mice 
and sham controls are shown in Table 1. LLC mice 
developed significant anemia represented by a decline 
in hemoglobin concentration (LLC 5.5 ± 0.3 vs. con-
trol 12.0 ± 0.8) and a hematocrit (LLC 18 ± 1.9 vs . 
control 37 ± 2.7). 
This anemia became apparent by day 3 (hemo-
globin 10,1 ± 0 .3 in LLC) and progressively worsened 
with growth of the tumor. Significant reticulocytosis 
also developed with counts becoming as high as 8.3 ± 
3 . 1 in tumor-bearing mice . In addition, leukocytosis 
with neutrophilia progressed from day 3 until the 
death of the animal (LLC 32,110 ± 8200, control 
2,514 ± 1100), In the bone marrow the myeloid: 
erythroid (M:E) ratio went from 1.2:1 in controls to 
as high as 3 .9:1 in LLC mice by day 7. By day 19 
the M:E ratio in tumor-bearing animals approached 
that of control. Significant splenomegaly developed 
progressively in LLC mice with the spleen increasing 
in size about 5 times (362 ± 27 ,9 vs. 77 ± 1.5 mg). 
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Figure 3. Electron micrograph of a section of bone marrow from the same mouse as the spleen in figure 2. 
Erythroblastic islands such as these were present in the marrow, with mitotic figures frequently seen. (M) 
mitosis. 
Fir;ire 4. Electron micrograph of a splenic sinus from the spleen of a 14 day tumor-bearing mouse . Note 
ev idence of active intralumenal erythropoiesis, with developing erythroid cells and mitoses . (M) mitosis, (E) 
er ythroid cell, (End) endothelial cell. 
Figure 5. Electron micrograph of a section of splenic red pulp of an LLC mouse 11 days post implantation. 
Macrophages such as this one were frequently seen in the process of digesting hemoglobinized red cell frag-
ments . (Mac) macrophage, (EI) erythroid inclusion. 
Figure 6. Electron micrograph of another splenic section from an LLC mouse, 7 days post implantation. A 
nucleus as well as hemoglobinized cell fragments of an erythroid cell have been ingested by a cordal macro-
phage. (EN) erythroid nucleus. 
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Microscopic findings 
By light microscopy the splenic red pulp, as 
well as marrow of tumor-bearing mice appeared 
markedly congested and hypercellular, with splenic 
cords containing numerous foci of hemopoiesis (Fig-
ure 1). This included all three lineages (erythro-
poiesis, granulopoiesis, and megakaryocytopoiesis). 
By comparison, the white pulp appeared somewhat 
small and hypotrophic. This congestion of red pulp 
progressed with growth of the tumor. Splenic si-
nuses contained many mature red cells but also nu-
merous hemopoietic foci, indicating the occurrence of 
intravascular erythropoiesis within the sinuses of 
spleen in tumor-bearing mice (Figure 1). Foci of 
hemopoiesis were also seen in electron microscopic 
preparations of both spleen and marrow (Figures 2, 
3). Erythropoietic foci usually could be perceived as 
surrounding a central macrophage, thus forming an 
erythroblastic island (2). Branches of central macro-
phages penetrated between developing erythroid cells 
which were often in the synchronous maturational 
stage. The central macrophage often contained red 
cell nuclei and sometimes entire nucleated crythroid 
cells. Mitotic figures were frequently seen in these 
islands (Figure 3). 
Intravascular erythropoiesis was also observed 
within the lumen of splenic sinuses, and again devel-
oping erythroid cells were in synchronous matura-
tional stages and mitoses not infrequently seen 
(Figure 4). 
Of much interest was the magnitude of phago-
cytosis by cordal macrophages (Figures 5, 6). This 
included both hemoglobinized fragments of erythroid 
cell cytoplasm as well as their nuclei and the entire 
cell. This erythrophagocytosis was the salient fea-
ture of spleen particularly after day 7 post implan-
tation. It was striking when compared to the spleen 
from sham control mice. No tumor cells were seen 
in marrow or spleen at anytime during the course of 
tumor development. 
Discussion 
The profound anemia that develops during the 
course of this experimental tumor is associated with 
progressive reticulocytosis, marrow hyperplasia and 
splenomegaly and suggest a hemolytic disorder . Nei-
ther the spleen nor the marrow is infiltrated by 
tumor. This is evident not only by the absence of 
tumor cells in these organs in our present micro-
scopic examination, but also by functional studies in 
which organ cell suspensions are subcutaneously im -
planted in new hosts. These implants never lead to 
tumor production. Hence, splenomegaly and marrow 
hyperplasia, observed in this study, should be inter-
preted in the context of anemia and other hematolo-
gic abnormalities as outlined in Table 1. 
In other experimental tumors, Wieman et al. 
(10) have shown the production of a hemolytic sub-
stance which can lyse normal red cells in vitro. 
Similarly, in clinical situations, hemolytic anemias 
are frequently associated with the presence of solid 
tumors (3, 6, 8) as well as hematological malignan-
cies. Further studies on the mechanism of hemolysis 
in this experimental tumor may shed some light on 
the mechanism of tumor-associated hemolytic disease 
in humans. 
Of further interest in this study was that 
erythropoietic response to hemolysis appeared to be 
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at least in part ineffective. This is evident by 
phagocytosis of immature cells in spleen as well as 
bone marrow. The reason for this ineffective eryth-
ropoiesis is not clear. It is possible, however, that 
the hemolytic factor responsible for destruction of 
mature cells may extend its effect to immature ones, 
thus leading to ineffective erythropoiesis. 
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Discussion with Reviewers 
H. Gamliel: If Lewis lung carcinoma invades the liver 
and kidneys too, why was "lung" (and not liver, etc.) 
attributed to this type of carcinoma? Can you spec-
ulate on why LLC invades the lungs, liver, and kid-
neys but not hemopoietic tissues? Studies of such a 
kind might contribute a lot in shedding more light 
on the mechanism of tumor infiltration. Are you 
aware of such studies? 
Authors: This is a very interesting question. LLC 
can potentially provide an excellent model to study 
the mechanism of metastasis in solid tumors. This is 
because of its highly predictable pattern of meta-
stasis. However, to our knowledge, this model sys-
tem has not been adequately exploited. Lung, (rath-
er than liver and kidney) metastasis is generally 
emphasized because it is the earliest and most pre-
dictable one. We feel this occurs because of the 
invasion of the venous system for which the lung is 
the first stop in the course of circulation. 
H. Gamliel: It seems that the description of eryth-
ropoietic foci surrounding a central macrophage is 
referring to the spleen only. If this is correct, are 
there comparable patterns of formation of such foci 
in the bone marrow? 
Authors: Yes, both tissues are involved. 
H. Gamliel: There is only limited information on the 
microstructure of the bone marrow in the studied 
samples. Compared to the describe changes in red 
and white pulp of the spleen, are there any such 
c hanges in the stroma of the bone marrow? 
Authors: We have not observed such changes and 
co nsequently we have not described any. 
H. Gamliel: Did you notice any macrophages or ma-
c rophage "branches" in close relation to granulo-
poiesis or megakaryocytopoiesis foci? Did you ever 
see fragments of myeloid or mega cells in the macro-
phages' cytoplasm? If not, what were your criteria 
for differentiating between immature erythroid frag-
ments and pieces from other immature blood cells? 
Compared to the "ineffective erythropoiesis," would 
you say that the mega- and/or granulopoiesis were 
(super) effective, as might be indicated in Table 1? 
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Authors: Probably ineffective hemopoiesis involves all 
three cell lines (erythropoiesis as well as granulo-
poiesis and megakaryocytopoiesis). However, the 
magnitude of granulopoiesis is so intense that the 
net result is blood granulocytosis. This intense 
granulopoiesis can be attributed to growth factor 
production by tumor cells as we have reported before 
( 1, 4). 
The mechanism of thrombocytopenia has always 
intrigued us. How much ineffective thrombocyto-
poiesis contributes to this is not known. This is an 
area that is currently under study. 
T. Seed: Is the early rise (at 7 days) in the M/E 
raho due to enhanced granulopoiesis or suppressed 
erythropoiesis, or both? 
Authors: This is due to enhanced granulopoiesis. We 
have previously reported (1,4) on this aspect. En-
hanced granulopoiesis in the course of this tumor is 
biphasic, with early and late phases. Both are the 
result of the production of GM-CSF and M-CSF by 
the tumor . 
T. Seed: Can LLC cells (or their soluble products) 
directly mediate, in vitro, similar proliferative/ 
suppressive responses? 
Authors: Yes. We have developed a cloned cell line 
from this tumor under serum-free conditions. Our 
data, as yet unpublished, indicate the elaboration of 
granulopoietic factors by this cell line. Whether 
there is a suppressive factor as well is currently 
under study. 
M. Kashimura : Congestion is usually used when ve-
nous blood stagnates. I doubt whether congestion is 
a proper word when the red pulp is occupied with 
erythrobl as tic islands. 
Authors : This definition could be applicable to those 
organs where the circulation is closed. In spleen 
with its characteristically open circulation, the 
situation is entirely different. Here the term has 
been used in any condition that leads to blockage of 
cordal pathways . 
